套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-012175 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001193125-20-133819 Act: 34 Size: 233 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011787 Size: 11 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011753 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011746 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011748 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011749 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011751 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011739 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-011740 Size: 5 KB 网页链接